Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
09 déc. 2024 07h25 HE
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced that the Magbot™ Magnetic...
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
21 oct. 2024 08h41 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
12 août 2024 16h03 HE
|
Stereotaxis, Inc.
Stereotaxis announced it has received CE mark & submitted a 510(k) application for its next-generation, semi-mobile robotic system, GenesisX.
U.S. Reprocessed Medical Devices Market Report 2024-2030: Third-party Reprocessing, In-house Reprocessing Size, Share & Trends Analysis - Increasing Emphasis on Costs Cutting
08 août 2024 11h10 HE
|
Research and Markets
Dublin, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The "U.S. Reprocessed Medical Devices Market Size, Share & Trends Analysis Report by Product Type (Cardiovascular), Type (Third-party Reprocessing,...
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
31 juil. 2024 09h45 HE
|
BioSig Technologies, Inc.
Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Global Left Atrial Appendage Closure Devices Market (2024-2034) to Witness 20.71% CAGR - Next-Gen LAAC Devices Revolutionizing Safety, Efficacy, and Accessibility in Cardiac Care
28 mai 2024 07h28 HE
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Global Left Atrial Appendage Closure Devices Market" report has been added to ResearchAndMarkets.com's offering.The global left atrial appendage...
Global Interventional Cardiology Devices Market Projected to Reach $21.9 Billion by 2030
08 avr. 2024 04h02 HE
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Global Interventional Cardiology Devices Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals & Clinics, Ambulatory...
Global Leadless Pacemakers Market Projected to Surpass $827.7 Million by 2030 with Notable Industry Advancements
04 avr. 2024 11h45 HE
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Global Leadless Pacemakers Market Size, Share & Industry Trends Analysis Report By Type (Micra Transcatheter Pacing System, and Others), By...
BioSig Announces Reduction of its Workforce
20 févr. 2024 10h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a...
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
06 févr. 2024 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...